{"id":25161,"date":"2023-09-15T11:55:00","date_gmt":"2023-09-15T16:55:00","guid":{"rendered":"https:\/\/myeloma.ca\/?p=25161"},"modified":"2025-08-19T08:28:10","modified_gmt":"2025-08-19T13:28:10","slug":"selinexor-maintenant-finance-en-saskatchewan","status":"publish","type":"post","link":"https:\/\/myeloma.ca\/fr\/2023\/09\/15\/selinexor-maintenant-finance-en-saskatchewan\/","title":{"rendered":"Selinexor maintenant financ\u00e9 en Saskatchewan!"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Nous sommes heureux d&rsquo;informer notre communaut\u00e9 que depuis le 1er septembre,<strong> XPOVIO\u00ae (selinexor) en association avec le bort\u00e9zomib et la dexam\u00e9thasone (XVd) pour le traitement des patients adultes atteints de my\u00e9lome multiple qui ont re\u00e7u au moins un traitement ant\u00e9rieur<\/strong>, est maintenant rembours\u00e9 en Saskatchewan.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Plus de d\u00e9tails sur les crit\u00e8res de remboursement ici : <a href=\"\" target=\"_blank\" rel=\"noopener\" title=\"\">Drug Formulary (saskcancer.ca).<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Nous sommes heureux d&rsquo;informer notre communaut\u00e9 que depuis le 1er septembre, XPOVIO\u00ae (selinexor) en association avec le bort\u00e9zomib et la dexam\u00e9thasone (XVd) pour le traitement des patients adultes atteints de my\u00e9lome multiple qui ont re\u00e7u au moins un traitement ant\u00e9rieur, est maintenant rembours\u00e9 en Saskatchewan. Plus de d\u00e9tails sur les crit\u00e8res de remboursement ici : [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_members_access_role":[],"_members_access_error":""},"categories":[50,1,52],"tags":[],"class_list":["post-25161","post","type-post","status-publish","format-standard","hentry","category-news-events","category-uncategorized","category-whats-new-at-myeloma-canada"],"acf":[],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.1.1 - aioseo.com -->\n\t<meta name=\"description\" content=\"Nous sommes heureux d&#039;informer notre communaut\u00e9 que depuis le 1er septembre, XPOVIO\u00ae (selinexor) en association avec le bort\u00e9zomib et la dexam\u00e9thasone (XVd) pour le traitement des patients adultes atteints de my\u00e9lome multiple qui ont re\u00e7u au moins un traitement ant\u00e9rieur, est maintenant rembours\u00e9 en Saskatchewan. Plus de d\u00e9tails sur les crit\u00e8res de remboursement ici :\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"lemieuxbedard\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/myeloma.ca\/fr\/2023\/09\/15\/selinexor-maintenant-finance-en-saskatchewan\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.1.1\" \/>\n\t\t<meta property=\"og:locale\" content=\"fr_FR\" \/>\n\t\t<meta property=\"og:site_name\" content=\"My\u00e9lome Canada |\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Selinexor maintenant financ\u00e9 en Saskatchewan! | My\u00e9lome Canada\" \/>\n\t\t<meta property=\"og:description\" content=\"Nous sommes heureux d&#039;informer notre communaut\u00e9 que depuis le 1er septembre, XPOVIO\u00ae (selinexor) en association avec le bort\u00e9zomib et la dexam\u00e9thasone (XVd) pour le traitement des patients adultes atteints de my\u00e9lome multiple qui ont re\u00e7u au moins un traitement ant\u00e9rieur, est maintenant rembours\u00e9 en Saskatchewan. Plus de d\u00e9tails sur les crit\u00e8res de remboursement ici :\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/myeloma.ca\/fr\/2023\/09\/15\/selinexor-maintenant-finance-en-saskatchewan\/\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2023-09-15T16:55:00+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2025-08-19T13:28:10+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Selinexor maintenant financ\u00e9 en Saskatchewan! | My\u00e9lome Canada\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Nous sommes heureux d&#039;informer notre communaut\u00e9 que depuis le 1er septembre, XPOVIO\u00ae (selinexor) en association avec le bort\u00e9zomib et la dexam\u00e9thasone (XVd) pour le traitement des patients adultes atteints de my\u00e9lome multiple qui ont re\u00e7u au moins un traitement ant\u00e9rieur, est maintenant rembours\u00e9 en Saskatchewan. Plus de d\u00e9tails sur les crit\u00e8res de remboursement ici :\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BlogPosting\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2023\\\/09\\\/15\\\/selinexor-maintenant-finance-en-saskatchewan\\\/#blogposting\",\"name\":\"Selinexor maintenant financ\\u00e9 en Saskatchewan! | My\\u00e9lome Canada\",\"headline\":\"Selinexor maintenant financ\\u00e9 en Saskatchewan!\",\"author\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/author\\\/lemieuxbedard\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/stage.myeloma.ca\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/logo_en.png\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/#articleImage\"},\"datePublished\":\"2023-09-15T11:55:00-05:00\",\"dateModified\":\"2025-08-19T08:28:10-05:00\",\"inLanguage\":\"fr-FR\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2023\\\/09\\\/15\\\/selinexor-maintenant-finance-en-saskatchewan\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2023\\\/09\\\/15\\\/selinexor-maintenant-finance-en-saskatchewan\\\/#webpage\"},\"articleSection\":\"News &amp; Events, Uncategorized, What's new at Myeloma Canada\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2023\\\/09\\\/15\\\/selinexor-maintenant-finance-en-saskatchewan\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/#listItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/category\\\/actualites-et-evenement\\\/#listItem\",\"name\":\"Actualit\\u00e9s et \\u00e9v\\u00e9nement\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/category\\\/actualites-et-evenement\\\/#listItem\",\"position\":2,\"name\":\"Actualit\\u00e9s et \\u00e9v\\u00e9nement\",\"item\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/category\\\/actualites-et-evenement\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/category\\\/actualites-et-evenement\\\/nouvelles-de-myelome-canada\\\/#listItem\",\"name\":\"Nouvelles de My\\u00e9lome Canada\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/#listItem\",\"name\":\"Accueil\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/category\\\/actualites-et-evenement\\\/nouvelles-de-myelome-canada\\\/#listItem\",\"position\":3,\"name\":\"Nouvelles de My\\u00e9lome Canada\",\"item\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/category\\\/actualites-et-evenement\\\/nouvelles-de-myelome-canada\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2023\\\/09\\\/15\\\/selinexor-maintenant-finance-en-saskatchewan\\\/#listItem\",\"name\":\"Selinexor maintenant financ\\u00e9 en Saskatchewan!\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/category\\\/actualites-et-evenement\\\/#listItem\",\"name\":\"Actualit\\u00e9s et \\u00e9v\\u00e9nement\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2023\\\/09\\\/15\\\/selinexor-maintenant-finance-en-saskatchewan\\\/#listItem\",\"position\":4,\"name\":\"Selinexor maintenant financ\\u00e9 en Saskatchewan!\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/category\\\/actualites-et-evenement\\\/nouvelles-de-myelome-canada\\\/#listItem\",\"name\":\"Nouvelles de My\\u00e9lome Canada\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/#organization\",\"name\":\"Myeloma Canada\",\"url\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/\",\"telephone\":\"+18887985771\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/stage.myeloma.ca\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/logo_en.png\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2023\\\/09\\\/15\\\/selinexor-maintenant-finance-en-saskatchewan\\\/#organizationLogo\"},\"image\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2023\\\/09\\\/15\\\/selinexor-maintenant-finance-en-saskatchewan\\\/#organizationLogo\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/author\\\/lemieuxbedard\\\/#author\",\"url\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/author\\\/lemieuxbedard\\\/\",\"name\":\"lemieuxbedard\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2023\\\/09\\\/15\\\/selinexor-maintenant-finance-en-saskatchewan\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/46bccf9afb319784ce7a4c49e51be67f2ed9bed19ab02f5f0a63c7aba8c80f06?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"lemieuxbedard\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2023\\\/09\\\/15\\\/selinexor-maintenant-finance-en-saskatchewan\\\/#webpage\",\"url\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2023\\\/09\\\/15\\\/selinexor-maintenant-finance-en-saskatchewan\\\/\",\"name\":\"Selinexor maintenant financ\\u00e9 en Saskatchewan! | My\\u00e9lome Canada\",\"description\":\"Nous sommes heureux d'informer notre communaut\\u00e9 que depuis le 1er septembre, XPOVIO\\u00ae (selinexor) en association avec le bort\\u00e9zomib et la dexam\\u00e9thasone (XVd) pour le traitement des patients adultes atteints de my\\u00e9lome multiple qui ont re\\u00e7u au moins un traitement ant\\u00e9rieur, est maintenant rembours\\u00e9 en Saskatchewan. Plus de d\\u00e9tails sur les crit\\u00e8res de remboursement ici :\",\"inLanguage\":\"fr-FR\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2023\\\/09\\\/15\\\/selinexor-maintenant-finance-en-saskatchewan\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/author\\\/lemieuxbedard\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/author\\\/lemieuxbedard\\\/#author\"},\"datePublished\":\"2023-09-15T11:55:00-05:00\",\"dateModified\":\"2025-08-19T08:28:10-05:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/\",\"name\":\"Myeloma Canada\",\"inLanguage\":\"fr-FR\",\"publisher\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Selinexor maintenant financ\u00e9 en Saskatchewan! | My\u00e9lome Canada","description":"Nous sommes heureux d'informer notre communaut\u00e9 que depuis le 1er septembre, XPOVIO\u00ae (selinexor) en association avec le bort\u00e9zomib et la dexam\u00e9thasone (XVd) pour le traitement des patients adultes atteints de my\u00e9lome multiple qui ont re\u00e7u au moins un traitement ant\u00e9rieur, est maintenant rembours\u00e9 en Saskatchewan. Plus de d\u00e9tails sur les crit\u00e8res de remboursement ici :","canonical_url":"https:\/\/myeloma.ca\/fr\/2023\/09\/15\/selinexor-maintenant-finance-en-saskatchewan\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BlogPosting","@id":"https:\/\/myeloma.ca\/fr\/2023\/09\/15\/selinexor-maintenant-finance-en-saskatchewan\/#blogposting","name":"Selinexor maintenant financ\u00e9 en Saskatchewan! | My\u00e9lome Canada","headline":"Selinexor maintenant financ\u00e9 en Saskatchewan!","author":{"@id":"https:\/\/myeloma.ca\/fr\/author\/lemieuxbedard\/#author"},"publisher":{"@id":"https:\/\/myeloma.ca\/fr\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/stage.myeloma.ca\/wp-content\/uploads\/2023\/02\/logo_en.png","@id":"https:\/\/myeloma.ca\/fr\/#articleImage"},"datePublished":"2023-09-15T11:55:00-05:00","dateModified":"2025-08-19T08:28:10-05:00","inLanguage":"fr-FR","mainEntityOfPage":{"@id":"https:\/\/myeloma.ca\/fr\/2023\/09\/15\/selinexor-maintenant-finance-en-saskatchewan\/#webpage"},"isPartOf":{"@id":"https:\/\/myeloma.ca\/fr\/2023\/09\/15\/selinexor-maintenant-finance-en-saskatchewan\/#webpage"},"articleSection":"News &amp; Events, Uncategorized, What's new at Myeloma Canada"},{"@type":"BreadcrumbList","@id":"https:\/\/myeloma.ca\/fr\/2023\/09\/15\/selinexor-maintenant-finance-en-saskatchewan\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/fr\/#listItem","position":1,"name":"Accueil","item":"https:\/\/myeloma.ca\/fr\/","nextItem":{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/fr\/category\/actualites-et-evenement\/#listItem","name":"Actualit\u00e9s et \u00e9v\u00e9nement"}},{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/fr\/category\/actualites-et-evenement\/#listItem","position":2,"name":"Actualit\u00e9s et \u00e9v\u00e9nement","item":"https:\/\/myeloma.ca\/fr\/category\/actualites-et-evenement\/","nextItem":{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/fr\/category\/actualites-et-evenement\/nouvelles-de-myelome-canada\/#listItem","name":"Nouvelles de My\u00e9lome Canada"},"previousItem":{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/fr\/#listItem","name":"Accueil"}},{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/fr\/category\/actualites-et-evenement\/nouvelles-de-myelome-canada\/#listItem","position":3,"name":"Nouvelles de My\u00e9lome Canada","item":"https:\/\/myeloma.ca\/fr\/category\/actualites-et-evenement\/nouvelles-de-myelome-canada\/","nextItem":{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/fr\/2023\/09\/15\/selinexor-maintenant-finance-en-saskatchewan\/#listItem","name":"Selinexor maintenant financ\u00e9 en Saskatchewan!"},"previousItem":{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/fr\/category\/actualites-et-evenement\/#listItem","name":"Actualit\u00e9s et \u00e9v\u00e9nement"}},{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/fr\/2023\/09\/15\/selinexor-maintenant-finance-en-saskatchewan\/#listItem","position":4,"name":"Selinexor maintenant financ\u00e9 en Saskatchewan!","previousItem":{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/fr\/category\/actualites-et-evenement\/nouvelles-de-myelome-canada\/#listItem","name":"Nouvelles de My\u00e9lome Canada"}}]},{"@type":"Organization","@id":"https:\/\/myeloma.ca\/fr\/#organization","name":"Myeloma Canada","url":"https:\/\/myeloma.ca\/fr\/","telephone":"+18887985771","logo":{"@type":"ImageObject","url":"https:\/\/stage.myeloma.ca\/wp-content\/uploads\/2023\/02\/logo_en.png","@id":"https:\/\/myeloma.ca\/fr\/2023\/09\/15\/selinexor-maintenant-finance-en-saskatchewan\/#organizationLogo"},"image":{"@id":"https:\/\/myeloma.ca\/fr\/2023\/09\/15\/selinexor-maintenant-finance-en-saskatchewan\/#organizationLogo"}},{"@type":"Person","@id":"https:\/\/myeloma.ca\/fr\/author\/lemieuxbedard\/#author","url":"https:\/\/myeloma.ca\/fr\/author\/lemieuxbedard\/","name":"lemieuxbedard","image":{"@type":"ImageObject","@id":"https:\/\/myeloma.ca\/fr\/2023\/09\/15\/selinexor-maintenant-finance-en-saskatchewan\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/46bccf9afb319784ce7a4c49e51be67f2ed9bed19ab02f5f0a63c7aba8c80f06?s=96&d=mm&r=g","width":96,"height":96,"caption":"lemieuxbedard"}},{"@type":"WebPage","@id":"https:\/\/myeloma.ca\/fr\/2023\/09\/15\/selinexor-maintenant-finance-en-saskatchewan\/#webpage","url":"https:\/\/myeloma.ca\/fr\/2023\/09\/15\/selinexor-maintenant-finance-en-saskatchewan\/","name":"Selinexor maintenant financ\u00e9 en Saskatchewan! | My\u00e9lome Canada","description":"Nous sommes heureux d'informer notre communaut\u00e9 que depuis le 1er septembre, XPOVIO\u00ae (selinexor) en association avec le bort\u00e9zomib et la dexam\u00e9thasone (XVd) pour le traitement des patients adultes atteints de my\u00e9lome multiple qui ont re\u00e7u au moins un traitement ant\u00e9rieur, est maintenant rembours\u00e9 en Saskatchewan. Plus de d\u00e9tails sur les crit\u00e8res de remboursement ici :","inLanguage":"fr-FR","isPartOf":{"@id":"https:\/\/myeloma.ca\/fr\/#website"},"breadcrumb":{"@id":"https:\/\/myeloma.ca\/fr\/2023\/09\/15\/selinexor-maintenant-finance-en-saskatchewan\/#breadcrumblist"},"author":{"@id":"https:\/\/myeloma.ca\/fr\/author\/lemieuxbedard\/#author"},"creator":{"@id":"https:\/\/myeloma.ca\/fr\/author\/lemieuxbedard\/#author"},"datePublished":"2023-09-15T11:55:00-05:00","dateModified":"2025-08-19T08:28:10-05:00"},{"@type":"WebSite","@id":"https:\/\/myeloma.ca\/fr\/#website","url":"https:\/\/myeloma.ca\/fr\/","name":"Myeloma Canada","inLanguage":"fr-FR","publisher":{"@id":"https:\/\/myeloma.ca\/fr\/#organization"}}]},"og:locale":"fr_FR","og:site_name":"My\u00e9lome Canada |","og:type":"article","og:title":"Selinexor maintenant financ\u00e9 en Saskatchewan! | My\u00e9lome Canada","og:description":"Nous sommes heureux d'informer notre communaut\u00e9 que depuis le 1er septembre, XPOVIO\u00ae (selinexor) en association avec le bort\u00e9zomib et la dexam\u00e9thasone (XVd) pour le traitement des patients adultes atteints de my\u00e9lome multiple qui ont re\u00e7u au moins un traitement ant\u00e9rieur, est maintenant rembours\u00e9 en Saskatchewan. Plus de d\u00e9tails sur les crit\u00e8res de remboursement ici :","og:url":"https:\/\/myeloma.ca\/fr\/2023\/09\/15\/selinexor-maintenant-finance-en-saskatchewan\/","article:published_time":"2023-09-15T16:55:00+00:00","article:modified_time":"2025-08-19T13:28:10+00:00","twitter:card":"summary_large_image","twitter:title":"Selinexor maintenant financ\u00e9 en Saskatchewan! | My\u00e9lome Canada","twitter:description":"Nous sommes heureux d'informer notre communaut\u00e9 que depuis le 1er septembre, XPOVIO\u00ae (selinexor) en association avec le bort\u00e9zomib et la dexam\u00e9thasone (XVd) pour le traitement des patients adultes atteints de my\u00e9lome multiple qui ont re\u00e7u au moins un traitement ant\u00e9rieur, est maintenant rembours\u00e9 en Saskatchewan. Plus de d\u00e9tails sur les crit\u00e8res de remboursement ici :"},"aioseo_meta_data":{"post_id":"25161","title":null,"description":null,"keywords":[],"keyphrases":{"focus":{"keyphrase":"","score":0,"analysis":{"keyphraseInTitle":{"score":0,"maxScore":9,"error":1}}},"additional":[]},"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":"","og_custom_url":null,"og_article_section":null,"og_article_tags":[],"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"BlogPosting","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":"-1","robots_max_videopreview":"-1","robots_max_imagepreview":"large","priority":null,"frequency":"default","local_seo":null,"breadcrumb_settings":null,"limit_modified_date":false,"ai":null,"created":"2023-12-15 16:58:25","updated":"2026-04-30 08:39:06","seo_analyzer_scan_date":null,"focus_keyword":null,"additional_keywords":null,"truseo_locale":null},"_links":{"self":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts\/25161","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/comments?post=25161"}],"version-history":[{"count":1,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts\/25161\/revisions"}],"predecessor-version":[{"id":25162,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts\/25161\/revisions\/25162"}],"wp:attachment":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/media?parent=25161"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/categories?post=25161"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/tags?post=25161"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}